$2.94
+0.17 (+6.14%)
Open$2.78
Previous Close$2.77
Day High$3.01
Day Low$2.78
52W High$37.94
52W Low$21.89
Volume—
Avg Volume725.9K
Market Cap99.98M
P/E Ratio46.73
EPS$0.65
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,196.9% upside
Current
$2.94
$2.94
Target
$38.13
$38.13
$23.34
$38.13 avg
$40.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.13M | 22.23M | 24.20M |
| Net Income | -3,425,590 | -3,026,461 | -3,348,387 |
| Profit Margin | -14.8% | -13.6% | -13.8% |
| EBITDA | -4,390,756 | -4,014,681 | -4,691,998 |
| Free Cash Flow | -2,646,725 | -2,971,274 | -2,303,520 |
| Rev Growth | +10.2% | +14.5% | +15.7% |
| Debt/Equity | 0.33 | 0.41 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |